Seminars in Colon & Rectal Surgery
Volume 19, Issue 1 , Pages 20-25 , March 2008

Outcomes after Local Excision for Rectal Cancer

  • Scott R. Steele, MD

      Affiliations

    • Department of Surgery, Madigan Army Medical Center, Tacoma, Washington.
  • ,
  • Anders Mellgren, MD, PhD

      Affiliations

    • Division of Colon and Rectal Surgery, University of Minnesota, Minneapolis, Minnesota.
    • Corresponding Author InformationAddress reprint requests to Anders Mellgren, Division of Colon & Rectal Surgery, University of Minnesota, 606 24th Avenue South, #515, Minneapolis, MN 55454.

References 

  1. American Cancer Society: Fact sheets: colorectal cancer. http://www.cancer.org/downloads/pro/colorectalcancer.pdfaccessed November 2007
  2. Avery KN, Metcalfe C, Nicklin J, Barham CP, Alderson D, Donovan JL, et al. Satisfaction with care: an independent outcome measure in surgical oncology. Ann Surg Oncol. 2006;13:817–822
  3. Longo WE, Virgo KS, Johnson FE, Wade TP, Vernava AM, Phelan MA, et al. Outcome after proctectomy for rectal cancer in Department of Veterans Affairs Hospitals: a report from the National Surgical Quality Improvement Program. Ann Surg. 1998;228:64–70
  4. Laurent C, Nobili S, Rullier A, Vendrely V, Saric J, Rullier E. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision. J Am Coll Surg. 2006;203:684–691
  5. Bonadeo FA, Vaccaro CA, Benati ML, Quintana GM, Garione XE, Telenta MT. Rectal cancer: local recurrence after surgery without radiotherapy. Dis Colon Rectum. 2001;44:374–379
  6. Peparini N, Maturo A, Di Matteo FM, Mele R, Benedetti F, Di Matteo G. Long-term survival and recurrences after total nerve-sparing surgery for rectal cancer. Hepatogastroenterology. 2006;53:850–853
  7. Delikoukos S, Zacharoulis D, Hatzitheofilou C. Electrocoagulation: an alternative palliative treatment for rectal cancer. Tech Coloproctol. 2004;8(Suppl 1):s76–s78
  8. Bailey HR, Huval WV, Max E, Smith KW, Butts DR, Zamora LF. Local excision of carcinoma of the rectum for cure. Surgery. 1992;111:555–561
  9. Frost DB, Wong R, Rao A. A retrospective comparison of transanal surgery and endocavitary radiation for the treatment of “early” rectal adenocarcinoma. Arch Surg. 1993;128:1028–1032
  10. Willett CG, Compton CC, Shellito PC, Efird JT. Selection factors for local excision or abdominoperineal resection of early stage rectal cancer. Cancer. 1994;73:2716–2720
  11. Bleday R, Breen E, Jessup JM, Burgess A, Sentovich SM, Steele G. Prospective evaluation of local excision for small rectal cancers. Dis Colon Rectum. 1997;40:388–392
  12. Brodsky JT, Richard GK, Cohen AM, Minsky BD. Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer. 1992;69:322–326
  13. Blumberg D, Paty PB, Guillem JG, Picon AI, Minsky BD, Wong WD, et al. All patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum. 1999;42:881–885
  14. Mellgren A, Sirivongs P, Rothenberger DA, Madoff RD, Garcia-Aguilar J. Is local excision adequate therapy for early rectal cancer?. Dis Colon Rectum. 2000;43:1064–1071
  15. Garcia-Aguilar J, Mellgren A, Sirivongs P, Buie D, Madoff RD, Rothenberger DA. Local excision of rectal cancer without adjuvant therapy: a word of caution. Ann Surg. 2000;231:345–351
  16. Paty PB, Nash GM, Baron P, Zakowski M, Minsky BD, Blumberg D, et al. Long-term results of local excision for rectal cancer. Ann Surg. 2002;236:522–529
  17. Thaler W, Watzka S, Martin F, La Guardia G, Psenner K, Bonatti G, et al. Preoperative staging of rectal cancer by endoluminal ultrasound vs. magnetic resonance imaging (Preliminary results of a prospective, comparative study). Dis Colon Rectum. 1994;37:1189–1193
  18. Meyenberger C, Huch Boni RA, Bertschinger P, Zala GF, Klotz HP, Krestin GP. Endoscopic ultrasound and endorectal magnetic resonance imaging: a prospective, comparative study for preoperative staging and follow-up of rectal cancer. Endoscopy. 1995;27:469–479
  19. Wolfman NT, Ott DJ. Endoscopic ultrasonography. Semin Roentgenol. 1996;31:154–161
  20. Garcia-Aguilar J, Pollack J, Lee SH, Hernandez de Anda E, Mellgren A, Wong WD, et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum. 2002;45:10–15
  21. Beynon J, Roe AM, Foy DM, Channer JL, Virjee J, Mortensen NJ. Preoperative staging of local invasion in rectal cancer using endoluminal ultrasound. J R Soc Med. 1987;80:23–24
  22. Sunouchi K, Sakaguchi M, Higuchi Y, Namiki K, Muto T. Limitation of endorectal ultrasonography: what does a low lesion more than 5 mm in size correspond to histologically?. Dis Colon Rectum. 1998;41:761–764
  23. Zheng YC, Zhou ZG, Li L, Lei WZ, Deng YL, Chen DY, et al. Distribution and patterns of lymph nodes metastases and micrometastases in the mesorectum of rectal cancer. J Surg Oncol. 2007;96:213–219
  24. Hager T, Gall FP, Hermanek P. Local excision of cancer of the rectum. Dis Colon Rectum. 1983;26:149–151
  25. Taylor RH, Hay JH, Larsson SN. Transanal local excision of selected low rectal cancers. Am J Surg. 1998;175:360–363
  26. Varma MG, Rogers SJ, Schrock TR, Welton ML. Local excision of rectal carcinoma. Arch Surg. 1999;134:863–867
  27. Sengupta S, Tjandra JJ. Local excision of rectal cancer: what is the evidence?. Dis Colon Rectum. 2001;44:1345–1361
  28. Chorost MI, Petrelli NJ, McKenna M, Kraybill WG, Rodriguez-Bigas MA. Local excision of rectal carcinoma. Am Surg. 2001;67:774–779
  29. You YN, Baxter NN, Stewart A, Nelson H. Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. Ann Surg. 2007;245:726–733
  30. Bouvet M, Milas M, Giacco GG, Cleary KR, Janjan NA, Skibber JM. Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum. Ann Surg Oncol. 1999;6:26–32
  31. Nissan A, Stojadinovic A, Shia J, Hoos A, Guillem JG, Klimstra D, et al. Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol. 2006;24:4078–4084
  32. Bentrem DJ, Okabe S, Wong WD, Guillem JG, Weiser MR, Temple LK, et al. T1 adenocarcinoma of the rectum: transanal excision or radical surgery?. Ann Surg. 2005;242:472–477
  33. Nascimbeni R, Nivatvongs S, Larson DR, Burgart LJ. Long-term survival after local excision for T1 carcinoma of the rectum. Dis Colon Rectum. 2004;47:1773–1779
  34. Madbouly KM, Remzi FH, Erkek BA, Senagore AJ, Baeslach CM, Khandwala F, et al. Recurrence after transanal excision of T1 rectal cancer: should we be concerned?. Dis Colon Rectum. 2005;48:711–719
  35. Friel CM, Cromwell JW, Marra C, Madoff RD, Rothenberger DA, Garcia-Aguilar J. Salvage radical surgery after failed local excision for early rectal cancer. Dis Colon Rectum. 2002;45:875–879
  36. Weiser MR, Landmann RG, Wong WD, Shia J, Guillem JG, Temple LK, et al. Surgical salvage of recurrent rectal cancer after transanal excision. Dis Colon Rectum. 2005;48:1169–1175
  37. Hahnloser D, Wolff BG, Larson DW, Ping J, Nivatvongs S. Immediate radical resection after local excision of rectal cancer: an oncologic compromise?. Dis Colon Rectum. 2005;48:429–437
  38. Steele GD, Herndon JE, Bleday R, Russell A, Benson A, Hussain M, et al. Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol. 1999;6:433–441
  39. Russell AH, Harris J, Rosenberg PJ, Sause WT, Fisher BJ, Hoffman JP, et al. Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of radiation therapy oncology group protocol 89-02. Int J Radiat Oncol Biol Phys. 2000;46:313–322
  40. Marks G, Mohiuddin MM, Masoni L, Pecchioli L. High-dose preoperative radiation and full-thickness local excision (A new option for patients with select cancers of the rectum). Dis Colon Rectum. 1990;33:735–739
  41. Mohiuddin M, Marks G, Bannon J. High-dose preoperative radiation and full thickness local excision: a new option for selected T3 distal rectal cancers. Int J Radiat Oncol Biol Phys. 1994;30:845–849
  42. Mohiuddin M, Regine WF, Marks GJ, Marks JW. High-dose preoperative radiation and the challenge of sphincter-preservation surgery for cancer of the distal 2 cm of the rectum. Int J Radiat Oncol Biol Phys. 1998;40:569–574
  43. Kim CJ, Yeatman TJ, Coppola D, Trotti A, Williams B, Barthel JS, et al. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg. 2001;234:352–358
  44. Perez RO, Habr-Gama A, Proscurshim I, Campos FG, Kiss D, Gama-Rodrigues J, et al. Local excision for ypT2 rectal cancer–much ado about something. J Gastrointest Surg. 2007;11:1431–1438
  45. Theodoropoulos G, Wise WE, Padmanabhan A, Kerner BA, Taylor CW, Aguilar PS, et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum. 2002;45:895–903
  46. Floyd ND, Saclarides TJ. Transanal endoscopic microsurgical resection of pT1 rectal tumors. Dis Colon Rectum. 2006;49:164–168
  47. Middleton PF, Sutherland LM, Maddern GJ. Transanal endoscopic microsurgery: a systematic review. Dis Colon Rectum. 2005;48:270–284
  48. Stipa F, Burza A, Lucandri G, Ferri M, Pigazzi A, Ziparo V, et al. Outcomes for early rectal cancer managed with transanal endoscopic microsurgery: a 5-year follow-up study. Surg Endosc. 2006;20:541–545
  49. Maslekar S, Pillinger SH, Monson JR. Transanal endoscopic microsurgery for carcinoma of the rectum. Surg Endosc. 2007;21:97–102
  50. Borschitz T, Heintz A, Junginger T. Transanal endoscopic microsurgical excision of pT2 rectal cancer: results and possible indications. Dis Colon Rectum. 2007;50:292–301
  51. Caricato M, Borzomati D, Ausania F, Tonini G, Rabitti C, Valeri S, et al. Complementary use of local excision and transanal endoscopic microsurgery for rectal cancer after neoadjuvant chemoradiation. Surg Endosc. 2006;20:1203–1207
  52. Lee WY, Lee WS, Yun SH, Shin SH, Chun HK. Decision for salvage treatment after transanal endoscopic microsurgery. Surg Endosc. 2007;21:975–979
  53. Demartines N, von Flue MO, Harder FH. Transanal endoscopic microsurgical excision of rectal tumors: indications and results. World J Surg. 2001;25:870–875
  54. Palma P, Freudenberg S, Samel S, Post S. Transanal endoscopic microsurgery: indications and results after 100 cases. Colorectal Dis. 2004;6:350–355
  55. Bretagnol F, Rullier E, George B, Warren BF, Mortensen NJ. Local therapy for rectal cancer: still controversial?. Dis Colon Rectum. 2007;50:523–533
  56. Brown G, Davies S, Williams GT, Bourne MW, Newcombe RG, Radcliffe AG, et al. Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging?. Br J Cancer. 2004;91:23–29
  57. Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U, Silva e Sousa AH, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240:711–717
  58. Bautista CV, Felis CP, Espinet JM, Garcia JB, Salas JV. Telomerase activity is a prognostic factor for recurrence and survival in rectal cancer. Dis Colon Rectum. 2007;50:611–620
  59. Iida A, Yamaguchi A, Hirose K. Telomerase activity in colorectal cancer and its relationship to bcl-2 expression. J Surg Oncol. 2000;73:219–223
  60. Giralt J, Navalpotro B, Hermosilla E, de Torres I, Espin E, Reyes V, et al. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy. Oncology. 2006;71:312–319
  61. Peng JJ, Cai SJ, Lu HF, Cai GX, Lian P, Guan ZQ, et al. Predicting prognosis of rectal cancer patients with total mesorectal excision using molecular markers. World J Gastroenterol. 2007;13:3009–3015
  62. Porter GA, Soskolne CL, Yakimets WW, Newman SC. Surgeon-related factors and outcome in rectal cancer. Ann Surg. 1998;227:157–167
  63. Harmon JW, Tang DG, Gordon TA, Bowman HM, Choti MA, Kaufman HS, et al. Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection. Ann Surg. 1999;230:404–411
  64. Read TE, Myerson RJ, Fleshman JW, Fry RD, Birnbaum EH, Walz BJ, et al. Surgeon specialty is associated with outcome in rectal cancer treatment. Dis Colon Rectum. 2002;45:904–914

PII: S1043-1489(08)00006-7

doi: 10.1053/j.scrs.2008.01.005

Seminars in Colon & Rectal Surgery
Volume 19, Issue 1 , Pages 20-25 , March 2008